✦ LIBER ✦

ChemInform Abstract: Synthesis of a SLex Mimic: A Potential E-Selectin Binding Antagonist.

✍ Scribed by B. M. HESKAMP; G. H. VEENEMAN; G. A. VAN DER MAREL; C. A. A. VAN BOECKEL; J. H. VAN BOOM

Book ID: 112027718
Publisher: John Wiley and Sons
Year: 2010
Weight: 34 KB
Volume: 27
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.199607254

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Synthesis of a SLex mimic: A potential E

Synthesis of a SLex mimic: A potential E-selectin binding antagonist

✍ B. M. Heskamp; G. H. Veeneman; G. A. van der Marel; C. A. A. van Boeckel; J. H. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 608 KB

ChemInform Abstract: Design and Synthesi

ChemInform Abstract: Design and Synthesis of (E)-Selectin Antagonists

✍ Beat Ernst; Zorica Dragic; Sebastien Marti; Christian Muller; Beatrice Wagner; W 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 25 KB 👁 2 views

ChemInform Abstract: Design and Synthesi

ChemInform Abstract: Design and Synthesis of a Macrocyclic E-Selectin Antagonist (I)

✍ H. C. KOLB 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 25 KB 👁 1 views

ChemInform Abstract: Synthesis and Biolo

ChemInform Abstract: Synthesis and Biological Evaluation of a Sialyl Lewis X Mimic with Significantly Improved E-Selectin Inhibition.

✍ Gebhard Thoma; John L. Magnani; John T. Patton 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 27 KB 👁 2 views

ChemInform Abstract: Drug Design, Synthe

ChemInform Abstract: Drug Design, Synthesis, and Evaluation of a Non-sugar-based Selectin Antagonist.

✍ Kyoko Fukunaga; Takahiro Tsukida; Hideki Moriyama; Hirosato Kondo 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 31 KB 👁 2 views

ChemInform Abstract: The Enantiospecific

ChemInform Abstract: The Enantiospecific Synthesis of an Isoxazoline. A RGD Mimic Platelet GPIIb/IIIa Antagonist.

✍ L. ZHANG; J. C. CHUNG; T. D. COSTELLO; I. VALVIS; P. MA; S. KAUFFMAN; R. WARD 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 31 KB 👁 1 views

The Enantiospecific Synthesis of an Isoxazoline. A RGD Mimic Platelet GPIIb/IIIa Antagonist. -The crystalline compound (VI), is synthesized on a multikilogram scale in 8 steps in 37% overall yield and ¿99.